Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386437886> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W4386437886 endingPage "7499" @default.
- W4386437886 startingPage "7492" @default.
- W4386437886 abstract "The aim of the study was to investigate the clinical effectiveness and safety of sclerotonyxis in acute angle-closure glaucoma (ACG) with persistent high intraocular pressure (IOP).The clinical data of 50 eyes from 50 patients (mean age: 68.9±7.19 years) with acute ACG and persistently high IOP who were admitted to our department between January 2012 and January 2022 were retrospectively analyzed. Patients who were administered the maximum dose of systemic and topical anti-glaucoma drugs and still had an IOP of >40 mmHg 24 hours after admission underwent sclerotonyxis. After the IOP control, an individualized phase II treatment plan was designed according to the patient's ocular condition.Forty-eight patients showed improvement in their visual acuity 6 months postoperatively compared to their preoperative values. The mean IOPs were 54.84±7.82 mmHg and 21.34±7.81 mmHg 24 hours pre and postoperatively, respectively. The mean anterior chamber depth showed statistically significant differences pre and postoperatively (1.75±0.16 mm and 1.84±0.17 mm, respectively) (p<0.05). After IOP stabilized, four patients underwent YAG laser peripheral iridectomy, 18 underwent simple cataract phacoemulsification combined with intraocular lens (IOL) implantation, 21 underwent cataract phacoemulsification combined with IOL implantation and goniosynechialysis under a gonioscope, and 7 patients underwent combined surgery of glaucoma and cataract. The mean IOPs were 15.94±3.3 mmHg and 15.64±2.99 mmHg 1 week and 6 months after stage II surgery, respectively. Moreover, 42 eyes (84%) attained complete success and 8 eyes (16%) attained conditional success 6 months postoperatively. No serious complications, such as corneal endothelial decompensation, malignant glaucoma, vitreous or eruptive choroidal hemorrhage, and retinal detachment, were observed intraoperatively or postoperatively in both procedures.Sclerotonyxis can rapidly lower IOP, release the pupillary blockage, reconstruct the anterior chamber, and reduce systemic complications caused by long-term high-dose antiglaucoma drugs. Thus, it normalizes the IOP and provides a safe operating space for stage II surgery, effectively reducing complications in patients in a persistent high IOP state." @default.
- W4386437886 created "2023-09-06" @default.
- W4386437886 creator A5004937113 @default.
- W4386437886 creator A5007226025 @default.
- W4386437886 creator A5065796070 @default.
- W4386437886 creator A5090229741 @default.
- W4386437886 date "2023-08-01" @default.
- W4386437886 modified "2023-10-16" @default.
- W4386437886 title "Clinical efficacy of sclerotonyxis for acute angle-closure glaucoma with persistent high intraocular pressure." @default.
- W4386437886 doi "https://doi.org/10.26355/eurrev_202308_33400" @default.
- W4386437886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37667925" @default.
- W4386437886 hasPublicationYear "2023" @default.
- W4386437886 type Work @default.
- W4386437886 citedByCount "0" @default.
- W4386437886 crossrefType "journal-article" @default.
- W4386437886 hasAuthorship W4386437886A5004937113 @default.
- W4386437886 hasAuthorship W4386437886A5007226025 @default.
- W4386437886 hasAuthorship W4386437886A5065796070 @default.
- W4386437886 hasAuthorship W4386437886A5090229741 @default.
- W4386437886 hasConcept C118487528 @default.
- W4386437886 hasConcept C141071460 @default.
- W4386437886 hasConcept C2778257484 @default.
- W4386437886 hasConcept C2778527774 @default.
- W4386437886 hasConcept C2779567214 @default.
- W4386437886 hasConcept C2781092963 @default.
- W4386437886 hasConcept C2781104129 @default.
- W4386437886 hasConcept C71924100 @default.
- W4386437886 hasConceptScore W4386437886C118487528 @default.
- W4386437886 hasConceptScore W4386437886C141071460 @default.
- W4386437886 hasConceptScore W4386437886C2778257484 @default.
- W4386437886 hasConceptScore W4386437886C2778527774 @default.
- W4386437886 hasConceptScore W4386437886C2779567214 @default.
- W4386437886 hasConceptScore W4386437886C2781092963 @default.
- W4386437886 hasConceptScore W4386437886C2781104129 @default.
- W4386437886 hasConceptScore W4386437886C71924100 @default.
- W4386437886 hasIssue "16" @default.
- W4386437886 hasLocation W43864378861 @default.
- W4386437886 hasOpenAccess W4386437886 @default.
- W4386437886 hasPrimaryLocation W43864378861 @default.
- W4386437886 hasRelatedWork W1628148152 @default.
- W4386437886 hasRelatedWork W2022049485 @default.
- W4386437886 hasRelatedWork W2049803900 @default.
- W4386437886 hasRelatedWork W2130385907 @default.
- W4386437886 hasRelatedWork W2334765154 @default.
- W4386437886 hasRelatedWork W2384752226 @default.
- W4386437886 hasRelatedWork W2762781727 @default.
- W4386437886 hasRelatedWork W2781673216 @default.
- W4386437886 hasRelatedWork W3114344278 @default.
- W4386437886 hasRelatedWork W4321610417 @default.
- W4386437886 hasVolume "27" @default.
- W4386437886 isParatext "false" @default.
- W4386437886 isRetracted "false" @default.
- W4386437886 workType "article" @default.